Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans
about
Noninvasive imaging of cardiovascular injury related to the treatment of cancerCancer treatment-related cardiac toxicity: prevention, assessment and management.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Cardiac complications of chemotherapy: role of imaging.Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography.Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.Anthracyclines and the heart.Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis.Chemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis.Increased beta2-adrenoceptors in doxorubicin-induced cardiomyopathy in rat.Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variablesDiastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors.Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 1: Definitions, Pathophysiology, Risk Factors, and Imaging.Anthracycline cardiotoxicity.Cardiotoxicity of cancer therapeutics: current issues in screening, prevention, and therapy.Liposomal Doxorubicin in the treatment of breast cancer patients: a reviewChemotherapy and cardiotoxicityAnthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.Anthracycline-induced cardiotoxicity: prospective cohort study from Pakistan.Cardiac functional evaluation using vector velocity imaging after chemotherapy including anthracyclines in children with cancer.Chemotherapy-induced cardiomyopathy.Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.Imaging methods for detection of chemotherapy-associated cardiotoxicity and dysfunction.Cardiotoxicity due to chemotherapy: role of cardiac imaging.Anthracycline-Induced Cardiomyopathy in Adults.Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.Echocardiographic Assessment of Cardiotoxic Effects of Cancer Therapy.A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia.Role of Imaging in Cardio-Oncology.Cardiotoxicity of cancer chemotherapy: identification, prevention and treatment.Abnormal myocardial calcium handling in the early stage of adriamycin cardiomyopathy.Cardiac functions evaluated with tissue Doppler imaging in childhood cancers treated with anthracyclines.Myocardial cytoprotection by trimetazidine against anthracycline-induced cardiotoxicity in anticancer chemotherapy.Concomitant impairment of left ventricular systolic and diastolic function during doxorubicin therapy: a prospective radionuclide ventriculographic and echocardiographic study.Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction.State of the art review: Chemotherapy-induced cardiotoxicity in children.Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults.The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.
P2860
Q27024715-D5F22F40-BE56-4DEC-8E14-FB93448A19F3Q30276456-494AABB0-0A3E-41A9-AD73-F8F81BC55AD7Q30401812-5943AC97-FBC9-4C95-80BC-A916F17F1D42Q30415201-69C40D36-1882-48CE-953D-D090E15014B3Q30446509-AE8EBB86-95B2-4039-8471-6C411ED3D23AQ30491590-4A75068E-0EAF-4B2C-92C6-D2C56BED394BQ33562971-3FCC2B92-4A27-4BAD-A43E-FE497E70F70DQ33613628-3C8F59DA-52F0-461E-93E2-4CA9A05BB9C9Q34535269-D8B168E6-6293-4568-B01D-3BB99ED64C48Q34659375-04FDC4F0-58B9-457A-AFA5-B6DD69C33958Q34760735-B02F5FA7-22BA-49E2-BAD8-17D986AC5F22Q35371321-ADE6EC76-DA38-4D28-A527-D988042D5B0CQ35915714-8C584BCE-46C8-4B34-839D-FEBCFC5C9EE5Q36451899-0E57F2DC-FD2A-450C-9CD4-E72C78F9C8BCQ36624983-224C11CB-1ECA-45BF-80CA-27D8000C4B3DQ36676062-8DE3DC4D-395F-44B1-A4DB-76E97FFF0B9FQ36748268-00DE01F1-9099-48C7-90CB-9F894AF633ADQ37045339-8ACAEFF9-5FF8-442F-AE78-9740C52B2592Q37059896-1F69A292-B9EE-4A53-BE30-6BD3EE9A546FQ37342407-B31B6A58-F490-4970-B42A-871BAE43A6AFQ37408759-DCD71D94-83CB-4569-8BEB-2F358CD37083Q37867085-10ECEC1E-E7F8-496F-B9C4-BA37D9607529Q38097736-26A4E45A-4529-4602-BC71-C22F50429A9FQ38197733-E51561E6-126B-421F-87A3-D98E0246DD34Q38343043-9C8704E1-3604-454E-BA50-ABC28589116AQ38542462-33CCD59E-81B8-4FEF-A9BA-9A09B0019D58Q38735433-978783F1-EB53-4C30-9C93-60AD53C2AA6DQ38853230-809911FC-A9D8-487D-8CBB-4D817C9E6E16Q38938410-AADF4451-C666-43C2-A61C-EDCC01EE5F01Q39198718-C324977C-0EF8-486D-A611-9754CDD42B03Q39285218-9E4722A7-24C2-4F9E-8832-CA555B2127EFQ41704131-72AD8F17-7A55-43C1-81F7-5DEB21A00610Q42553927-D3F2445B-B1AD-471F-8819-65121D4F2540Q43178517-9C878A68-982D-4730-BFD8-0322DF3043BAQ44391942-6B4628BC-F5C1-49A4-87C5-EB84DE990260Q44397250-6CDAF903-7CFD-40BA-A294-C6FA3115690BQ45218584-B9FD09D6-0001-42BE-8DCA-FE37BE6498F4Q48143732-23989D50-6B9B-4507-9E52-ECD8622D23F8Q51801559-9A8E6466-0D53-47AC-ADA4-247F4A544233Q52982588-CA21981F-FD91-4F83-AB32-833B6DC09EA5
P2860
Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Prolongation of isovolumetric ...... systolic dysfunction in humans
@ast
Prolongation of isovolumetric ...... systolic dysfunction in humans
@en
Prolongation of isovolumetric ...... systolic dysfunction in humans
@nl
type
label
Prolongation of isovolumetric ...... systolic dysfunction in humans
@ast
Prolongation of isovolumetric ...... systolic dysfunction in humans
@en
Prolongation of isovolumetric ...... systolic dysfunction in humans
@nl
prefLabel
Prolongation of isovolumetric ...... systolic dysfunction in humans
@ast
Prolongation of isovolumetric ...... systolic dysfunction in humans
@en
Prolongation of isovolumetric ...... systolic dysfunction in humans
@nl
P2093
P1476
Prolongation of isovolumetric ...... systolic dysfunction in humans
@en
P2093
D M Sullivan
J Kupersmith
M F Stoddard
N E Liddell
T J Hadley
P356
10.1016/0735-1097(92)90138-D
P407
P577
1992-07-01T00:00:00Z